Medical treatment of glaucoma began in the late 1800s with physostigmine and pilocarpine. In the United States, glaucoma treatment usually begins with topical medications.
It is now clear that pathophysiologically glaucoma is a progressive loss of ganglion cells due to increased intraocular pressure, leading to visual field defects.
